CEPP regimen: Difference between revisions
No edit summary |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
{{PAGENAME}} refers to a regimen consisting of cyclophosphamide, etoposide, procarbazine and prednisone used to treat atypical presentation of Hodgkin lymphoma with severe abnormal liver function.<ref name="pmid24991411">{{cite journal| author=Thakar K, Novero A, Das A, Lisinschi A, Mehta B, Ahmed T et al.| title=CEPP regimen (cyclophosphamide, etoposide, procarbazine and prednisone) as initial treatment for Hodgkin lymphoma patients presenting with severe abnormal liver function. | journal=Biomark Res | year= 2014 | volume= 2 | issue= | pages= 12 | pmid=24991411 | doi=10.1186/2050-7771-2-12 | pmc=PMC4078319 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24991411 }} </ref> | {{PAGENAME}} refers to a regimen consisting of [[cyclophosphamide]], [[etoposide]], [[procarbazine]] and [[prednisone]] used to treat atypical presentation of [[Hodgkin lymphoma]] with severe abnormal liver function.<ref name="pmid24991411">{{cite journal| author=Thakar K, Novero A, Das A, Lisinschi A, Mehta B, Ahmed T et al.| title=CEPP regimen (cyclophosphamide, etoposide, procarbazine and prednisone) as initial treatment for Hodgkin lymphoma patients presenting with severe abnormal liver function. | journal=Biomark Res | year= 2014 | volume= 2 | issue= | pages= 12 | pmid=24991411 | doi=10.1186/2050-7771-2-12 | pmc=PMC4078319 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24991411 }} </ref> | ||
==Regimen== | ==Regimen== | ||
| Line 18: | Line 18: | ||
==Indications== | ==Indications== | ||
[[Hodgkin lymphoma]] with severe abnormal liver function | *[[Hodgkin lymphoma]] with severe abnormal liver function.<ref name="pmid24991411">{{cite journal| author=Thakar K, Novero A, Das A, Lisinschi A, Mehta B, Ahmed T et al.| title=CEPP regimen (cyclophosphamide, etoposide, procarbazine and prednisone) as initial treatment for Hodgkin lymphoma patients presenting with severe abnormal liver function. | journal=Biomark Res | year= 2014 | volume= 2 | issue= | pages= 12 | pmid=24991411 | doi=10.1186/2050-7771-2-12 | pmc=PMC4078319 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24991411 }} </ref> | ||
==References== | ==References== | ||
Latest revision as of 15:02, 11 March 2015
|
WikiDoc Resources for CEPP regimen |
|
Articles |
|---|
|
Most recent articles on CEPP regimen Most cited articles on CEPP regimen |
|
Media |
|
Powerpoint slides on CEPP regimen |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on CEPP regimen at Clinical Trials.gov Clinical Trials on CEPP regimen at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on CEPP regimen
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on CEPP regimen Discussion groups on CEPP regimen Patient Handouts on CEPP regimen Directions to Hospitals Treating CEPP regimen Risk calculators and risk factors for CEPP regimen
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for CEPP regimen |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:Cyclophosphamide/Etoposide/Prednisone/Procarbazine
Overview
CEPP regimen refers to a regimen consisting of cyclophosphamide, etoposide, procarbazine and prednisone used to treat atypical presentation of Hodgkin lymphoma with severe abnormal liver function.[1]
Regimen
Ccyclophosphamide
Eetoposide
Pprocarbazine
Pprednisone
Indications
- Hodgkin lymphoma with severe abnormal liver function.[1]
References
- ↑ 1.0 1.1 Thakar K, Novero A, Das A, Lisinschi A, Mehta B, Ahmed T; et al. (2014). "CEPP regimen (cyclophosphamide, etoposide, procarbazine and prednisone) as initial treatment for Hodgkin lymphoma patients presenting with severe abnormal liver function". Biomark Res. 2: 12. doi:10.1186/2050-7771-2-12. PMC 4078319. PMID 24991411.